Literature DB >> 3660593

Altered ratios of measles virus transcripts in diseased human brains.

R Cattaneo1, G Rebmann, K Baczko, V ter Meulen, M A Billeter.   

Abstract

In rare cases measles virus (MV) induces subacute sclerosing panencephalitis (SSPE) or measles inclusion body encephalitis (MIBE), two lethal diseases of the human central nervous system. MV transcripts present in the brains of two SSPE patients and one MIBE patient were analyzed by quantitative Northern blots. In all three cases the transcripts from the first MV gene were relatively abundant, amounting to about one-tenth of that in lytically infected cells. However, the quantity of transcripts decreased sharply for each subsequent MV gene, arriving at 200-fold lower levels for the fifth MV gene. In comparison gradients of transcript levels are more shallow in either lytically or persistently infected cultured cells, where the transcripts of the fifth MV gene are only about five times less abundant than those of the first. These altered ratios of mRNAs appear to be typical for persistent MV brain infections and most likely lead to reduced expression of the viral envelope proteins, encoded by distal MV genes, at the surface of brain cells. This could account for the lack of viral budding and allow persistent MV infections to elude immune surveillance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3660593     DOI: 10.1016/0042-6822(87)90031-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis.

Authors:  G D Parks; K R Ward; J C Rassa
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 2.  Blood-brain barrier genomics, proteomics, and new transporter discovery.

Authors:  Eric V Shusta
Journal:  NeuroRx       Date:  2005-01

3.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice.

Authors:  Makoto Takeda; Shinji Ohno; Maino Tahara; Hiroki Takeuchi; Yuta Shirogane; Hirofumi Ohmura; Takafumi Nakamura; Yusuke Yanagi
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

5.  Tyrosine phosphorylation of measles virus P-phosphoprotein in persistently infected neuroblastoma cells.

Authors:  R Ofir; Y Weinstein; E Bazarsky; S Blagerman; M Wolfson; T Hunter; B Rager-Zisman
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Characterization of human parainfluenza virus type 3 persistent infection in cell culture.

Authors:  A Moscona; M S Galinski
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

7.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation.

Authors:  Benjamin R tenOever; Marc J Servant; Nathalie Grandvaux; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.

Authors:  Laura E Luque; Olga A Bridges; John N Mason; Kelli L Boyd; Allen Portner; Charles J Russell
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine.

Authors:  Satya Parida; Madhuchhanda Mahapatra; Sai Kumar; Subash C Das; Michael D Baron; John Anderson; Thomas Barrett
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.